Jing Qian co-founded the Center for China Analysis (CCA) at the Asia Society Policy Institute alongside the Hon. Dr. Kevin Rudd, to whom he served as a Senior Advisor for almost a decade. As the Managing Director of CCA, Jing leads its strategy, research, and policy work on China, which includes coordination of a series of Track 1.5/2 dialogues. Jing also co-leads the Decoding Chinese Politics, Cure4Cancer International Clinical Trials Collaboration projects, and the Dragon & Eagle: U.S.-China Rising Leaders Council. 

Jing serves as an Advisory Board Member of the Bloomberg New Economy Forum and is a co-founder of the Bloomberg New Economy International Cancer Coalition and a foundering member of the AstraZeneca Global Health Equity Advisory Board. Jing is also a Senior Fellow at the Munk School of Global Affairs and Public Policy at the University of Toronto.

Jing’s own research is focused on China's elite politics and its impact on China's domestic and foreign policy, particularly regarding U.S.-China relations. His analyses have appeared in Bloomberg, BBC, CBC, Harvard Business Review, Nature, Nature Medicine, New York Times, South China Morning Post, The Economist, Wall Street Journal, etc.  

A graduate of Harvard, Jing is deeply interested in the liberal arts. He co-founded Project Agora, with H.E. George Papandreou, aiming to educate the citizens and citizen-leaders for our society through the transformative power of a liberal arts education.